GENEWIZ Expands Next Generation Sequencing Services With Cancer Panels
(firmenpresse) - SOUTH PLAINFIELD, NJ -- (Marketwire) -- 12/03/12 -- , leading global genomic service provider, announced today expansion of their Next Generation Sequencing service portfolio to include . Available through and platforms, Cancer Panels enable GENEWIZ to screen for genetic mutations proven to play a role in cancer.
Advanced next generation sequencing technologies enable cancer panels to target over fifty cancer genes with deep sequencing, providing a high depth of coverage sensitive enough to detect rare mutations from a very small amount of DNA.
"NGS-based cancer panels allow for rapid analysis of multiple genes at a considerably lower price compared to traditional sequencing techniques," stated Dr. Yankai Jia, Director of GENEWIZ Next Generation Sequencing. "The large amount of data generated is highly technical, so it's important for researchers to have a trusted partner throughout the process who can provide the customized support and scientific expertise required."
In addition to offering the and Cancer Panels, GENEWIZ is actively developing custom cancer panels in effort to further advance cancer research, biomarker discovery, clinical diagnostics, and personalized medicine.
For more information about GENEWIZ Next Generation Sequencing Cancer Panels, please .
is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; San Diego, CA; Washington, DC Metro; Research Triangle Park, NC; and Seattle, WA. International locations include Beijing, China; Suzhou, China; and London, United Kingdom.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.12.2012 - 10:00 Uhr
Sprache: Deutsch
News-ID 208752
Anzahl Zeichen: 0
contact information:
Town:
SOUTH PLAINFIELD, NJ
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 235 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GENEWIZ Expands Next Generation Sequencing Services With Cancer Panels"
steht unter der journalistisch-redaktionellen Verantwortung von
GENEWIZ, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
